Tradestie Institutional Equity Comparison Engine

LCTX vs VTYX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VTYX Overall Edge

VTYX Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ventyx Biosciences, Inc. Common Stock (VTYX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while LCTX counters with relative strength in Valuation. Fundamentally, LCTX trades at 30.7x Forward P/E with -280.3% operating margin (-61.0% YoY revenue) versus VTYX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LCTX sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LCTX
LCTX 30.7x vs VTYX N/M Fwd P/E
Growth & Margin Winner VTYX
Op Margin -280.3% vs 0.0% ยท YoY -61.0% vs +0.0%
Momentum & Technical Winner VTYX
1Y -54.9% vs +786.1% ยท 52W Pos 0% vs 55%
Options & Structure Winner VTYX
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
LCTX NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.77
-5.87% 1D
Market Cap $207.4M
1M Return -21.63%
1Y Return -54.86%
Forward P/E 30.7x
Unified AI Score
54.9 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 72.0 Mom 45.0
VTYX NASDAQ
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
1M Return +0.36%
1Y Return +786.08%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LCTX -54.86% VTYX +786.08% Spread: +37.31 pp (VTYX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LCTX TTM Op. Margin: -280.3% VTYX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LCTX vs VTYX. Trailing 12-month operating profitability (LCTX -280.3% vs VTYX 0.0%) and valuation multiples (LCTX 30.7x vs VTYX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LCTX (5) vs VTYX (5)
Institutional Metric LCTX VTYX Criterion Row Winner
Market Capitalization Scale $207.4M $1.0B Larger Scale VTYX
Trailing P/E Ratio Valuation 30.7x N/M Lower Multiple LCTX
Forward P/E Ratio Valuation 30.7x N/M Lower Multiple LCTX
Revenue Growth (YoY) Growth -61.0% +0.0% Higher Growth VTYX
Operating Margin (TTM) Profitability -280.3% 0.0% Higher Margin VTYX
Net Profit Margin Profitability 16.2% 0.0% Higher Margin LCTX
Return on Equity (ROE) Capital Efficiency 4.3% -45.4% Higher ROE LCTX
52-Week Range Position Momentum 0% ($1โ€“$2) 55% ($1โ€“$25) Stronger Trend VTYX
Beta / 30D Volatility Risk Regime 1.39ฮฒ ยท 79% Vol 2.07ฮฒ ยท 2% Vol Lower Realized Risk VTYX
Unified Institutional Score Composite Signal 54.9 / 100 (HOLD) 50.4 / 100 (HOLD) Higher Composite LCTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LCTX vs VTYX Buy Guide
LCTX BREAKDOWN
7d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live LCTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VTYX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VTYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LCTX nor VTYX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.